Skip to main content
SpringerLink
Log in

Blood Pressure Control in Chronic Dialysis Patients

  • Chapter
Book cover Replacement of Renal Function by Dialysis

  • 180 Accesses

Abstract

Proper blood pressure control is an essential prerequisite to patient longevity. For patients treated with maintenance dialysis, blood pressure monitoring and modification acquire even a more paramount position.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Linder A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697, 1974

    Google Scholar 

  2. Lowrie EG, Lazarus JM, Hampers CL, Merrill JP: Cardiovascular disease in dialysis patients. N Engl J Med 290: 737, 1974

    PubMed  CAS  Google Scholar 

  3. Merrill JP: Cardiovascular problems in patients on long-term hemo-dialysis. (editorial) JAMA 228: 1149, 1974

    PubMed  CAS  Google Scholar 

  4. Rao TKS, Manis T, Delano BG, Friedman EA: Continuing high morbidity during maintenance hemodialysis consequent to bilateral nephrectomy. Trans Am Soc Artif Intern Organs 19: 340, 1973

    PubMed  CAS  Google Scholar 

  5. White RP, Sealey J, Reidenberg M, Stenzel KH, Sullivan JF, David DS, Laragh JH, Rubin AL: Mechanisms of blood pressure control in anephrics: Plasma renin and dopamines-hydroxylase activity. Trans Am Soc Artif Intern Organs 22: 420, 1976

    PubMed  CAS  Google Scholar 

  6. Lazarus JM, Hampers CL, Merrill JP: Hypertension in chronic renal failure. Arch Intern Med 133: 1059, 1974

    PubMed  CAS  Google Scholar 

  7. Wilkinson R, Scott DF, Uldall PR, Kerr DNS, Swinney J, Robson V: Plasma renin and exchangeable sodium in hypertension of chronic renal failure. The effect of bilateral nephrectomy. Q J Med 39: 377, 1970

    PubMed  CAS  Google Scholar 

  8. Stoker GS, Mani MK, Stewart JH: Relevance of salt water and renin to hypertension in chronic renal failure. Br Med J 3: 126, 1970

    Google Scholar 

  9. Comty CM, Baillod RA, Crockett R, Shaldon S: Forty months experience with nurse operated chronic dialysis units. Proc Eur Dial Transpl Assoc 3: 98, 1966

    Google Scholar 

  10. Weidman P, Maxwell MH: Hypertension, in Clinical Aspects of Uremia and Dialysis, edited by Massry SG, Sellers AL; Springfield, IL, Charles C Thomas, 1976, p 100

    Google Scholar 

  11. Dathram JRE, Goodwin FJ: The relationship between body fluid compartment volume, renin and blood pressure on chronic renal failure. Clin Sci 42: 29, 1972.

    Google Scholar 

  12. Weidman P, Maxwell MH, Lupu AN, Lewin AJ, Massry SG: Plasma renin activity and blood pressure in terminal renal failure. N Engl J Med 285: 757, 1971

    Google Scholar 

  13. Vertes V, Cangiano JL, Berman LB, Gould A: Hypertension in endstage renal disease. N Engl J Med 280: 978, 1971

    Google Scholar 

  14. Brown JJ, Curtis JR, Lever AF, Robertson JIS, De Wardener HE, Wing AJ: Plasma renin concentration and control of blood pressure in patients on hemodialysis. Nephron 6: 329, 1969

    PubMed  CAS  Google Scholar 

  15. De Quattro V, Chan S: Raised plasma catecholamines in some patients with hypertension. Lancet 1: 806, 1972

    Google Scholar 

  16. Atuk N, Roman J, Westervelt F: Catecholamines, renin and hypertension in terminal renal failure. Proc Fifth Internat Congr Nephrol, 1972, p 115

    Google Scholar 

  17. White RP, Reidenburg MM, Stenzel KH, Rubin AL: Dopamines-hydroxylase and blood pressure levels in renal failure. Am Soc Nephrol (Abstract) 9: 51, 1976

    Google Scholar 

  18. Blumberg A, Nelp WB, Hegstrom RM, Scribner BH: Extracellular volume in patients with chronic renal disease treated for hypertension by sodium restriction. Lancet 2: 69, 1967

    PubMed  CAS  Google Scholar 

  19. Merrill JP, Schupak E: Mechanisms of hypertension in renoprival man. Can Med Assoc J 90: 328, 1964

    PubMed  CAS  Google Scholar 

  20. Dustan HP, Page IH: Some factors in renal and renoprival hypertension. J Lab Clin Med 64: 948, 1964

    PubMed  CAS  Google Scholar 

  21. Onesti O, Swartz C, Ramirez O, Brest AN: Bilateral nephrectomy for control of hypertension in uremia. Trans Am Soc Artif Intern Organs 14: 361, 1968

    PubMed  CAS  Google Scholar 

  22. Vander AJ: Effect of catecholamines and the renal nerves on renin secretion on anesthetized dogs. Am J Physiol 209: 659, 1965

    PubMed  CAS  Google Scholar 

  23. Johnson JA, Davis JO, Witty RJ. Effects of catecholamines and renal nerve stimulation on renin release in the nonfiltering kidney. CircRes 29: 646, 1971

    PubMed  CAS  Google Scholar 

  24. Reid IA, Schrier RW, Earley LE: An effect of extra renal beta adrenergic stimulation on the release of renin. J Clin Invest 51: 1861, 1972

    PubMed  CAS  Google Scholar 

  25. Tobian L, Tomboulian A, Janecek J: Effect of high perfusion pressures on granulation of juxtaglomerular cells in isolated kidney. J Clin Invest 38: 605, 1959

    PubMed  CAS  Google Scholar 

  26. Skinner SL, McCubbin JW, Page IH: Control of renin secretion. Circ. Res. 15: 64, 1964

    PubMed  CAS  Google Scholar 

  27. Thurau K, Schnermann J, Nagel W, Harstu M, Wahl M: Composition of tubular fluid in the macula densa segment as a factor regulating the function of the juxtaglomerular apparatus. CircRes 20–21 (suppl II): 79, 1967

    Google Scholar 

  28. Freeman RM, Davis JO, Gotshall RW, Johnson JA, Spielman WS: The signal perceived by the macula densa during changes in renin release. Circ Res 35: 307, 1974

    CAS  Google Scholar 

  29. Brunner HR, Gavras M, Laragh JH, Kennan R: Angiotensin II blockade in man by sar’-ala’-angiotensin II for understanding and treatment of high blood pressure. Lancet 2: 1045, 1973

    PubMed  CAS  Google Scholar 

  30. Gavras M, Brunner HR, Laragh JH, Sealey JS, Gavras I, Vukovich RA: An angiotensin-converting enzyme inhibitior to identify and treat vasoconstrictor and volume factors in hypertensive patients. N Engl J Med 291: 817, 1974

    PubMed  CAS  Google Scholar 

  31. Reis DJ, Duba N: The central nervous system and neurogenic hypertension. Prog Cardiovasc Dis 17: 51, 1974

    PubMed  CAS  Google Scholar 

  32. Folkow B: Central neurohormonal mechanisms in spontaneously hypertensive cats compared with human essential hypertension. Clin Sci 48: 2055, 1975

    Google Scholar 

  33. Ferrario CM, Gildenburg PL, McCubbin JW: Cardiovascular effects of angiotensin mediated by central nervous system. Circ Res 30: 257, 1972

    PubMed  CAS  Google Scholar 

  34. Feldberg W, Lewis GP: The action of peptides on the adrenal medulla: Release of adrenaline by bradykinin and angiotensin. J Physiol (London) 171: 98, 1964

    CAS  Google Scholar 

  35. Peach MJ, Cline WH Jr, Watts DT: Release of adrenal (catecholamines) by angiotensin II. Circ Res 19: 571, 1966

    PubMed  CAS  Google Scholar 

  36. Peach MJ: Adrenal medullary stimulation induced by angiotensin I, angiotensin II and analogues. Circ Res 28, 29 (suppl II): 107, 1971

    Google Scholar 

  37. Brunjes S: Catecholamine metabolism in essential hypertension. N Engl J Med 271: 120, 1964

    PubMed  CAS  Google Scholar 

  38. Nestel PJ, Esler MD: Patterns of catecholamine excretion in urine in hypertension. Circ Res 26, 27 (suppl II): 75, 1970

    Google Scholar 

  39. De Quattro V: Evaluation of increased norepinephrine excretion in hypertension using L-dopa-3H. Circ Res 28: 84, 1971

    Google Scholar 

  40. Engelman K, Portnoy B: A sensitive double isotope derivative assay for norepinephrine and epinephrine: Normal resting human plasma levels. Circ Res 26: 53, 1970

    PubMed  CAS  Google Scholar 

  41. Louis WJ, Doyle AE, Anavekar S: Plasma norepinephrine levels in essential hypertension. N Engl J Med 288: 599, 1973

    PubMed  CAS  Google Scholar 

  42. Atuk NO, Westervelt FB Jr, Roman J: The role of endogenous catecholamines on the plasma renin activity and hypertension in renal failure. Clin Res 21: 94, 1973

    Google Scholar 

  43. Atuk NO, Bailey CJ, Turner S, Peach MJ, Westervelt FB Jr: Red blood cell catechol-o-methyl transferase, plasma catecholamines and renin in renal failure. Trans Am Soc Artif Intern Organs 22: 195, 1976

    PubMed  CAS  Google Scholar 

  44. Levin EY, Levenberg B, Kaufman S: The enzymatic conversion of 3,4 dihydroxyphenylethylamine to norepinephrine. J Biol Chem 235: 2080, 1960

    PubMed  CAS  Google Scholar 

  45. Creveling CR, Daly JW, Witkop B, Udenfriend S: Substrates and inhibitors of dopamines-hydroxylase. Biochim Biophys Acta 64: 125, 1972

    Google Scholar 

  46. Craine JE, Daniels GH, Kaufman S: Dopamines-hydroxylase. The subunit structure and anion activation of the bovine adrenal enzyme. J. Biol Chem 248: 7838, 1973

    PubMed  CAS  Google Scholar 

  47. Weinshilbowm RM, Thoa NB, Johnson DB, Kopin I J, Axelrod J: Proportional release of norepinephrine and dopamines-hydroxylase from sympathetic nerves. Science 174: 1349, 1971

    Google Scholar 

  48. Geffen L: Serum dopamines-hydroxylase as an index of sympathetic function. Life Sci 14: 1593, 1974

    PubMed  CAS  Google Scholar 

  49. Nagatsu T, Udenfriend S: Photometric assay of dopamines-hydroxylase activity in human blood. Clin Chem 18: 980, 1972

    PubMed  CAS  Google Scholar 

  50. Rush RA, Geffen LB: Radioimmunoassay and clearance of circulating dopamines-hydroxylase. Circ Res 31: 444, 1972

    PubMed  CAS  Google Scholar 

  51. Schanberg SM, Stone RA, Kirshner N, Gunnells JC, Robinson RR: Plasma dopamines-hydroxylase: A possible aid in the study and evaluation of hypertension. Science 183: 523, 1974

    PubMed  CAS  Google Scholar 

  52. Stone RA, Gunnells JC, Robinson RR, Schanberg SM, Kirshner N: Dopamines-hydroxylase in primary and secondary hypertension. Circ Res (suppl) 1: 34, 1974

    Google Scholar 

  53. Geffen LB, Rush RA, Louis WJ, Doyle AE: Plasma dopamines-hydroxylase and noradrenaline amounts in essential hypertension. Clin Sci 44: 617, 1973

    PubMed  CAS  Google Scholar 

  54. Horwitz D, Alexander RW, Lovenberg W, Keiser HR: Human serum dopamines-hydroxylase: Relationship to hypertension and sympathetic activity. Circ Res 32: 594, 1973

    PubMed  CAS  Google Scholar 

  55. Aberg H, Wetterberg L, Ross SB, Froden O: Dopamines-hydroxylase in hypertension. Acta Med Scand 196: 17, 1974

    PubMed  CAS  Google Scholar 

  56. Kapin IJ, Kaufman S, Viveros H, Jacobowitz D, Lake R, Ziegler MG, Lovenberg W, Goodwin FK: NIH Conference: Dopamines-hydroxylase basic and clinical studies. Ann Intern Med 85: 211, 1976

    Google Scholar 

  57. Ross SB, Wetterberg L, Myrhed M: Genetic control of plasma-dopamines-hydroxylase. Life Sci 12: 529, 1973

    PubMed  CAS  Google Scholar 

  58. Ogihara T, Nugent C, Shen S, Goldfein S: Serum dopamines-hydroxylase activity in parents and children. J Lab Clin Med 85: 566, 1975

    PubMed  CAS  Google Scholar 

  59. Duke M, Abelman WH: The hemodynamic response to chronic anemia. Circulation 39: 503, 1969

    PubMed  CAS  Google Scholar 

  60. Neff MS, Kim KE, Persoff M, Onesti G, Swartz C: Hemodynamics of uremic anemia. Circulation 43: 876, 1971

    PubMed  CAS  Google Scholar 

  61. Kim KE, Onesti G, Schwartz AB, Chinitz JL, Swartz C: Hemodynamics of hypertension in chronic end stage renal disease. Circulation 46: 456, 1972

    PubMed  CAS  Google Scholar 

  62. Lilley JJ, Golden J, Stone RA: Adrenergic regulation of blood pressure in chronic renal failure. J Clin Invest 57: 1190, 1976

    PubMed  CAS  Google Scholar 

  63. McGilvery RW: Biochemistry A Functional Approach. Philadelphia PA, Saunders Co, 1970 p 571

    Google Scholar 

  64. Anderson RJ, Berl T, McDonald KM, Schrier RW: Prostaglandins: Effects on blood pressure, renal blood flow, sodium and water excretion, editorial review. Kidney Int 10: 205, 1976

    PubMed  CAS  Google Scholar 

  65. Lee JB, Co vino BG, Takman BH, Smith ER: Renomedullary vasodepressor substance, medullin. Isolation, chemical characterization and physiological properties. Circ Res 17: 57, 1965

    PubMed  CAS  Google Scholar 

  66. Flower R, Gryglewski R, Herbaczynska-Cedro K, Vane JR: Effects of antiinflammatory drugs on prostaglandin biosynthesis. Nature (New Biol) 238: 104, 1972

    CAS  Google Scholar 

  67. Lee JB, Mookerjee BK: The renal prostaglandins as etiologic factors in human essential hypertension: fact or fantasy? Cardiovasc Med 1: 302, 1976

    Google Scholar 

  68. Safar M, Fendler JP, Weil B, Beuve-Mery P, Brisset JM, Idatti JM, Meyer P, Milliez P: Hypertension in patients on maintenance haemodialysis. Rev Eur Etud Clin Biol 15: 740, 1970

    PubMed  CAS  Google Scholar 

  69. Coburn JW, Massry SG, DePalma JR, Shinaberger JH: Rapid appearance of hypercalcemia with initiation of hemodialysis. JAMA 210: 2276, 1969

    PubMed  CAS  Google Scholar 

  70. Weidman P, Massry SG, Coburn JW, Maxwell MH, Atleson J, Kleeman CR: Blood pressure effects of acute hypercalcemia. Studies in patients with chronic renal failure. Ann Intern Med 76: 741, 1972

    Google Scholar 

  71. Fichman MP, Littenberg G, Brooker G, Horton R: The effect of prostaglandin A t (PGA on renal and adrenal function in man. CircRes (suppl.) 31: 19, 1972

    Google Scholar 

  72. Gregory LF, Durrett, R, Robinson RR, Clapp JR: The short term effect of furosemide on electrolyte and water excretion in patients with severe renal disease. Ann Intern Med 125: 69, 1970

    CAS  Google Scholar 

  73. Rastogi SP, Volans G, Eliott RW, Eccleston DW, Ashcroft R, Webster D, Kerr DNS: High dose furosemide in the treatment of hypertension in renal insufficiency and of terminal renal failure. Postgrad MedJAl–A5, 1971

    Google Scholar 

  74. Allison MEM, Kennedy AL: Diuretics in chronic renal disease: A study of high dosage furosemide. Clin Sci 41: 171, 1971

    PubMed  CAS  Google Scholar 

  75. Rado JP, Juhos E, Szends L, Marosi J, Tako J, Salmon F: Acute renal effects of high doses of furosemide administered intravenously in patients with advanced renal insufficiency. J Med (Basel) 4: 219, 1973

    CAS  Google Scholar 

  76. Kelly MR, Cutler RE, Christopher TG, Forrey AW: Pharmacokinetics of furosemide in normal subjects and anephric patients. Clin Res 21: 470, 1973

    Google Scholar 

  77. Mitchell JR, McMurty RJ, Statham CN, Nelson SD: Molecular basis for several drug-induced nephropathies. Am J Med 62: 518, 1977

    PubMed  CAS  Google Scholar 

  78. Pillay VKG, Schwartz FD, Aimi K, Kark RM: Transient and permanent deafness following treatment with ethacrynic acid in renal failure. Lancet 1: 77, 1969

    PubMed  CAS  Google Scholar 

  79. Kotchen TA, Knight EL, Kashgarian M, Mulrow PJ: A study of the renin-angiotensin system in patients with chronic renal insufficiency. Nephron 7: 317, 1970

    PubMed  CAS  Google Scholar 

  80. Kotchen TA, Rice TW, Walters DR: Renin reactivity in normal, hypentensive and uremic plasma. J Clin Endocrinol Metab 34: 928, 1972

    PubMed  CAS  Google Scholar 

  81. Sealey JE, White RP, Laragh JH, Rubin AL: Prorenin and renin substrate in plasma from nephrectomized man. Clin Sci Mol Med (Abstract) 24:411 A, 1976

    Google Scholar 

  82. Case DB, Wallace JM, Keim HJ, Sealey JE, Laragh JH: Usefulness and limitations of Saralasin, a partial competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patients. Am J Med 60: 825, 1976

    PubMed  CAS  Google Scholar 

  83. Donker AJM, Leenan FHM: Infusion of angiotensin II analogue in two patients with unilateral renovascular hypertension. Lancet 2: 1535, 1974

    PubMed  CAS  Google Scholar 

  84. Brunner HR, Gavras H, Laragh JH: Specific inhibition of the renin-angiotensin system: A key to understanding blood pressure regulation. Prog Cardiovasc Dis 17: 87, 1974

    PubMed  CAS  Google Scholar 

  85. Mimran A, Shaldon S, Mathieu MN, Polito C, Barjon P and Mion C: The hypertension of long term hemodialysis patients: Studies with angiotensin II antagonist (PI 13). Trans Am Soc Artif Intern Organs 22: 9, 1976

    PubMed  CAS  Google Scholar 

  86. Case DB, Wallace JM, Keim HJ, Weber MA, Drayer JIM, White RP, Sealey JE, Laragh JH: Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over Saralasin. Am J Med 61: 790, 1976

    PubMed  CAS  Google Scholar 

  87. White RP, Byrd LH, Case DB, Sullivan JF, Laragh JH, Rubin AL: Testing for angiotensin dependency with converting enzyme inhibition compared to renin levels in hypertensive hemodialysis patients. Am Soc Nephrol (Abstract) 10: 56A, 1977

    Google Scholar 

  88. Ferreira SH, Bartelt DC and Green LJ: Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 9: 2583, 1970

    PubMed  CAS  Google Scholar 

  89. Needleman P, Doublas JR Jr, Jakshik BA, Blumberg AL, Isakson PC, Marshall GR: Angiotensin antagonists as pharmacological tools. Fed Proc 35: 2488, 1976.

    PubMed  CAS  Google Scholar 

  90. Needlemen P, Johnson EM Jr, Vine W, Flanigan E, Marshall GR: The pharmacology of antagonists of angiotensin I and II. CircRes 31: 862, 1972

    Google Scholar 

  91. Buhl er FR, Laragh JH, Vaughan ED Jr, Brunner HR, Gavras H, Baer L: Antihypertensive action of propranolol. Am J Cardiol 32: 511, 1973

    PubMed  CAS  Google Scholar 

  92. Buhl er FR, Laragh JH, Baer L, Vaughan ED Jr, Brunner HR: Propranolol inhibition in renin secretion. N Engl J Med 287, 1209, 1972

    PubMed  CAS  Google Scholar 

  93. Winer N, Choski DS, Yoon MS, Freedman AD: Adrenergic receptor mediation of renin secretion. J Clin Endocrinol Metab 29: 1168, 1969

    PubMed  CAS  Google Scholar 

  94. Michelakis AM, McAllister RG: The effect of chronic adrenergic receptor blockade on plasma renin activity in man. J Clin Endocrinol Metab 34: 386, 1972

    PubMed  CAS  Google Scholar 

  95. Hollinfield JW, Sherman K, Vander Swagg R, Shand DG: Proposed mechanisms of propranolol’s antihypertensive effect in essential hypertension. N Engl J Med 295: 68, 1976

    Google Scholar 

  96. Lewis P: The essential action of propranolol in hypertension. Am J Med 60: 837, 1976

    PubMed  CAS  Google Scholar 

  97. Stumpe KO, Kolloch R, Vetter H, Gramann W, Krück F, Rersel CH, Higuchi M: Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure. Am J Med 60: 853, 1976

    PubMed  CAS  Google Scholar 

  98. Davies R, Slater JDM: Is the adrenergic control of renin release dominant in man? Lancet 2: 594, 1976

    PubMed  CAS  Google Scholar 

  99. Evans GH, Shand DG: Disposition of propranolol. Drug accumulation and steady state concentrations during oral administration in man. Clin Pharmacol Ther 14: 487, 1973

    PubMed  CAS  Google Scholar 

  100. Nies AS, Shand DG: Clinical pharmacology of propranolol. Circulation 52: 6, 1975

    PubMed  CAS  Google Scholar 

  101. Thompson FD, Joekes AM, Foulkes: Pharmacodynamics of propranolol in renal failure. Br Med J 2: 434, 1976

    Google Scholar 

  102. Thompson FD, Joekes AM: Beta blockade in the presence of renal disease and hypertension. Br Med J 2: 555, 1974

    PubMed  CAS  Google Scholar 

  103. Holland OB, Kaplan NM: Propranolol in the treatment of hypertension. N Engl J Med 294: 930, 1976

    PubMed  CAS  Google Scholar 

  104. Berglund G, Andersson O, Hansson L, Olander R: Propranolol given twice daily in hypertension. Acta MedScand 194: 513, 1973

    PubMed  CAS  Google Scholar 

  105. Wilkinson PR, Dixon N, Hunter KR: Twice daily propranolol treatment for hypertension. J Intern Med Res 2: 220, 1974

    Google Scholar 

  106. Drayer JIM, Keim HJ, Weber MA, Case DB, Laragh JM: Unexpected pressor responses to propranolol in essential hypertension: Am J Med 60: 897, 1976

    PubMed  CAS  Google Scholar 

  107. Hollifield J, Sherman K, Shand DG: Propranolol’s proposed dual antihypertensive activity. Circulation 52 (suppl) 2: 98, 1975

    Google Scholar 

  108. Smith EC, Dhar SK, Freedman P: Propranolol in the management of hypertension in long term dialysis programs. JAMA 229, 1777, 1974

    PubMed  CAS  Google Scholar 

  109. Myhre E, Brodwell EK, Stenback O, Hansen T: Plasma turnover of methyldopa in advanced renal failure. Acta MedScand 191: 343, 1972

    PubMed  CAS  Google Scholar 

  110. Yeh BK, Dayton PG, Waters WC III: Removal of a methyldopa (Aldomet) in man by dialysis. Proc Soc Exp Biol Med 135: 840, 1970

    PubMed  CAS  Google Scholar 

  111. McMartin C, Simpson P: The absorption and metabolism of guanethedine in hypertensive patients requiring different doses of the drug. Clin Pharmac Ther 12: 73, 1971

    CAS  Google Scholar 

  112. Boura ALA, Green AF: Adrenergic neurone blocking agents. Ann Rev Pharmacol 5: 183, 1965

    CAS  Google Scholar 

  113. Onesti G, Schwartz AB, Kim KE: Antihypertensive effect on Clonidine. Cire Res (suppl) 2: 53, 1971

    Google Scholar 

  114. Hansson L, Hunyor SN, Julius S, Hoobler SW: Blood pressure crisis following withdrawal of Clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels and suggestions for acute management. Am Heart J 85: 605, 1973

    PubMed  CAS  Google Scholar 

  115. Atterhög JM, Duner H, Pernow B: Experience with Pindolol, a beta-receptor blocker, in the treatment of hypertension. Am J Med 60: 872, 1976

    PubMed  Google Scholar 

  116. Menard J, Bertagna X, Tamn’Guyen P, Degoulet P, Carvol P: Rapid identification of patients with essential hypertension sensitive to- acebutolol (a new cardioselective beta-blocker). Am J Med 60: 880, 1976

    Google Scholar 

  117. Lorimer AR, Dunn FG, Jones JV, Lawrie TDV: Beta-adrenoreceptor blockade in hypertension. Am J Med 60: 877, 1976

    PubMed  CAS  Google Scholar 

  118. Sandler G, Leishman AWD, Humberston PM: Guanethidine-resistant hypertension. Circulation 38: 542, 1968

    PubMed  CAS  Google Scholar 

  119. Ross EJ, Prichard BNC, Kaufman L, Robertson AIG, Harries BJ: Preoperative and operative management of patients with phaeochromocytoma. Br Med J 1: 191, 1967

    PubMed  CAS  Google Scholar 

  120. Reidenberg MM, Drayer D, De Marco AL, Dello CT: Hydralazine elimination in man. Clin Pharmacol Ther 14: 970, 1973

    PubMed  CAS  Google Scholar 

  121. Gottlieb TB, Thomas RC, Chidsey CA: Parmacokinetic studies of minoxidil. Clin Pharmacol Ther 13: 436, 1972

    PubMed  CAS  Google Scholar 

  122. Limas CJ, Freis ED: Minoxidil in severe hypertension with renal failure. Am J Cardiol 31: 355, 1973

    PubMed  CAS  Google Scholar 

  123. Pettinger WA, Mitchell HC: Minoxidil: An alternative to nephrectomy for refractory hypertension. N Engl J Med 289: 167, 1973

    PubMed  CAS  Google Scholar 

  124. Ryan JR, Jain AK, McMahon FG: Minoxidil treatment of severe hypertension. Curr Ther Res 17: 55, 1975

    PubMed  CAS  Google Scholar 

  125. Mehta PK, Mamdani B, Shansky RM, Mahurkar SD, Dunea G: Severe hypertension treatment with Minoxidil. JAMA 233: 249, 1975

    PubMed  CAS  Google Scholar 

  126. Hess HJ: Prazosin: Biochemistry and structure-activity studies. Postgrad Med (special issue):9, 1975

    Google Scholar 

  127. Hayes JM, Graham RM, O’Connell PO: Experience with prazosin in the treatment of patients with severe hypertension. Med J Aust 1: 562, 1976

    PubMed  CAS  Google Scholar 

  128. Okun R: Long term efficacy and safety of prazosin in essential hypertension. Postgrad Med (special issue): 63, 1975

    Google Scholar 

  129. Gabriel R, Meek D, Ghosh BC: Letter to editor: Collapse after prazosin HCl. Lancet 1: 1095, 1975

    PubMed  CAS  Google Scholar 

  130. Moulds RFW, Jauernig RA: Letter to editor: Mechanisms of prazosin collapse. Lancet 1: 200, 1977

    PubMed  CAS  Google Scholar 

  131. Stokes GS, Weber MA: Prazosin (Minipress) - Preliminary report and comparative studies using other antihypertensive agents. Br Med J 2: 298, 1974

    PubMed  CAS  Google Scholar 

  132. Bloom DS, Rosendorff C, Kramer R: Clinical evaluation of prazosin as the sole agent for the treatment of hypertension, A double-blind crossover study with methyldopa. Curr Ther Res 18: 144, 1975

    PubMed  CAS  Google Scholar 

  133. O’Malley K, Velasco M, Pruitt A, McNay JC: Decreased plasma binding of diazoxide in uremia. Clin Pharmacol Ther 18: 53, 1975

    PubMed  Google Scholar 

  134. Koch-Weser J: Drug Therapy: Diazoxide. N Engl J Med 294: 1271, 1976

    PubMed  CAS  Google Scholar 

  135. Muirhead EE, Brooks B, Aurora KK: Prevention of malignant hypertension by the synthetic peptide SQ 20881. Lab Invest 30: 129, 1974

    CAS  Google Scholar 

  136. Franciosa FA Jr, Guiha NH, Limas CJ, Rodriguera E, Cohn JN: Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet 1: 650, 1972

    PubMed  CAS  Google Scholar 

  137. Ross G, Cole PV: Cardiovascular actions of sodium nitroprusside in dogs. Anaesthesia 28: 400, 1973

    PubMed  CAS  Google Scholar 

  138. Palmer RF, Lasseter KC: Sodium nitroprusside. N Engl J Med 292: 294, 1975

    PubMed  CAS  Google Scholar 

  139. Cheigh JS, Rubin AL, Stenzel KM, Whitsell JC: Hypocalcemia following bilateral nephrectomy. Urology 2: 121, 1973

    PubMed  CAS  Google Scholar 

  140. Stenzel KH, Cheigh JC, Sullivan JS, Tapia L, Riggio RR, Rubin AL: Clinical effects of bilateral nephrectomy. Am J Med 58: 69, 1975

    PubMed  CAS  Google Scholar 

  141. van Ypersele de Strihou C, Stragier A: Effect of bilateral nephrectomy on transfusion requirement of patients undergoing chronic dialysis. Lancet 2: 705, 1969

    Google Scholar 

  142. Kominami N, Lowrie EG, Ianberg LE, Skaren A, Hampers CL, Merill JP, Lange RD: The effect of total nephrectomy on hematopoiesis in patients undergoing chronic hemodialysis. J Lab Clin Med 78: 524, 1971

    PubMed  CAS  Google Scholar 

  143. Martin WB, Zins GR, Greyburger WA: The use of minoxidil in 510 patients with refractory hypertension. Clin Sci Mol Med 48: 1895, 1975

    Google Scholar 

  144. McCarron DA, Rubin RJ, Barnes BA, Harrington JT, Millan VG: Therapeutic bilateral renal infarction in end stage renal disease. N Engl J Med 294: 502, 1976

    Google Scholar 

  145. Avram MM, Lipner HI, Gan AL: Medical nephrectomy. The use of metallic salts for the control of massive proteinuria in the nephrotic syndrome. Trans Am Soc Artif Intern Organs 22: 431, 1976

    PubMed  CAS  Google Scholar 

  146. Morland JJ, Rottembourg J, Jardin A, Thibault P, Rouby JJ, Jacobs C, Legrain M: Selective bilateral renal artery embolization (RAE) as treatment of malignant hypertension in two repetitive dialysis patients. Société de Néphrologie, Paris, May 1976. Kidney Int (Abstract) 10: 338, 1976

    Google Scholar 

  147. Alfrey AC, Goss JE, Ogden DA, Vogel JHK, Holmes JH: Uremic hemopericardium. Am J Med 45: 391, 1968.

    PubMed  CAS  Google Scholar 

  148. Szmuness W, Prince AM, Grady GF, Mann MK, Levine RW, Friedman EA, Jacobs MS, Josephson A, Ribat S, Shapiro FL, Stenzel KH, Suki WN, Vyas G: Hepatitis B infection a point prevalence study in 15 US hemodialysis centers. JAMA 227: 901, 1974

    PubMed  CAS  Google Scholar 

  149. Hindman SH, Gravelle CR, Murphy BL, Bradley DW, Budge WR, Maynard JE: “e” antigen, dane particles, and serum DNA polymerase activity in HBS Ag carriers. Ann Intern Med 85: 458, 1976

    PubMed  CAS  Google Scholar 

  150. Grady GF: Collaborative study: Relationship of e antigen to infectivity of HBS Ag positive inoculations among medical personnel. Lancet 2: 492, 1976

    Google Scholar 

  151. Deheneffe J, Cuesta V, Briggs JD, Brown JJ, Leckie BJ, Lever AF, Morton JJ, Robertson JIS,Semple PF, Tree M: The renin-angiotensin system in anephric man. Proc Eur Dial Transpl Assoc 13: 495, 1976

    Google Scholar 

  152. Weinberger MH, Aoi W, Wade MB, Usa T, Grim CE, Dentino ME, Luft F: Renin-like activity in anephric man. Am Soc Nephrol (Abstract) 9: 51, 1976

    Google Scholar 

  153. Ganten D, Schelling P, Vecsci P, Ganten U: Iso-renin of extra-renal origin. The tissue angioten- sinogenase system. Am J Med 60: 760, 1976

    PubMed  CAS  Google Scholar 

  154. Sealey JE, Moon C, Laragh JH, Alderman M: Plasma prorenin: Cryoactivation and relationship to renin substrate in normal subjects. Am J Med 61: 731, 1976

    PubMed  CAS  Google Scholar 

  155. Sealey JE, White RP, Laragh JH, Rubin AL: Plasma prorenin and renin in anephric patients. Circ Res 41 (Suppl IT): 17, 1977

    PubMed  CAS  Google Scholar 

  156. Davis JO, Carpenter CCJ, Ayers CR, Halman JE, Bahn RC: Evidence for secretion of an aldosterone- stimulating hormone by the kidney. J Clin Invest 40: 684, 1961

    PubMed  CAS  Google Scholar 

  157. McCaa RE, McCaa CS, Read VH, Bower JD, Guyton AL: Increased plasma aldosterone concentration in response to hemodialysis in nephrectomized man. Circ Res 31: 473, 1972

    PubMed  CAS  Google Scholar 

  158. McCaa RE, McCaa CS, Read VH, Bower JD: Influence of hemodialysis on plasma aldosterone concentration in nephrectomized patients. Trans Am Soc Artif Intern Organs 18:239 and 248, 1972

    Google Scholar 

  159. Vetter W, Zaruba K, Armbuster H, Beckerhoff R, Reck G, Siegenthaler W: Control of plasma aldosterone in supine anephric man. Clin Endocrinol (Oxf) 3: 411, 1974

    CAS  Google Scholar 

  160. Woods TJC, McCaa RE, Bower JD, McCaa CS: Aldosterone response to angiotensin II in patients with femoral renal failure and after bilateral nephrectomy. Trans Am Soc Artif Intern Organs 20: 154, 1974

    Google Scholar 

  161. Goodwin TJ, James VHT, Peart WS: The control of aldosterone secretion in nephrectomized man. Clin Sci Mol Med 47: 235, 1974

    PubMed  CAS  Google Scholar 

  162. Dekeneffe J, Cuesta V, Roberston J: (Letter): The control of aldosterone in anephric man. Clin Sci Mol Med 48: 465, 1975

    Google Scholar 

  163. Sealey JE, White RP, Laragh JH: Virtual absence of plasma aldosterone in anephric patients. J Clin Endocrinol Metab 1978

    Google Scholar 

  164. Weidman P, Maxwell MH, Rowe P, Winer R, Massry SG: Role of the renin-angiotensin-aldosterone system in the regulation of plasma potassium in chronic renal disease. Nephron 15: 35, 1975

    Google Scholar 

  165. Kersh ES, Kronfield SJ, Unger A, Popper RW, Cantor S, Cohn K: Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension. N Engl J Med 290: 650, 1974

    PubMed  CAS  Google Scholar 

  166. Henderson LW, Lilley JJ, Ford CA, Stone RA: Hemodiafiltration. J Dialysis 1: 211, 1977

    CAS  Google Scholar 

  167. Chaimovitz C, Abinader B, Benderly A, Better OS: Hypocalcemic hypotension. JAMA 222: 86, 1972

    PubMed  CAS  Google Scholar 

  168. Nidus B, Matalon R, Katz L, Cabaluna C, Pan C, Esinger R: Hemodialysis using femoral vein cannula- tion. Nephron 13: 416, 1974

    PubMed  CAS  Google Scholar 

  169. Le Veen HH, Wapnick S, Grosberg S, Kinney MJ: Further experience with peritoneo-venous shunt for ascites. Ann Surg 184: 574, 1976

    Google Scholar 

Download references

Authors
  1. Robert P. White
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John F. Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kurt H. Stenzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Albert L. Rubin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, University of Amsterdam, Netherlands

    William Drukker M.D. (Formerly Reader in Dialysis Emeritus Director) (Formerly Reader in Dialysis Emeritus Director)

  2. Department of Nephrology and Dialysis, St. Lucas Hospital, Amsterdam, The Netherlands

    William Drukker M.D. (Formerly Reader in Dialysis Emeritus Director) (Formerly Reader in Dialysis Emeritus Director)

  3. 75 De Lairessestreet, 1071 NV, Amsterdam, The Netherlands

    William Drukker M.D. (Formerly Reader in Dialysis Emeritus Director) (Formerly Reader in Dialysis Emeritus Director)

  4. Renal Research Unit, Wellcome Wing, The General Infirmary at Leeds, LS1 3EX, Leeds, UK

    Frank M. Parsons B.Sc., M.D., F.R.C.P. Ed. (Consultant Physician Senior Clinical Lecturer in Renal Medicine) (Consultant Physician Senior Clinical Lecturer in Renal Medicine)

  5. University of Leeds, UK

    Frank M. Parsons B.Sc., M.D., F.R.C.P. Ed. (Consultant Physician Senior Clinical Lecturer in Renal Medicine) (Consultant Physician Senior Clinical Lecturer in Renal Medicine)

  6. Health Center, University of Connecticut, 06032, Farmington, CT, USA

    John F. Maher M.D., F.A.C.P. (Professor of Medicine, Director Division of Nephrology) (Professor of Medicine, Director Division of Nephrology)

Rights and permissions

Reprints and permissions

Copyright information

© 1979 Martinus Nijhoff Publishers bv, The Hague

About this chapter

Cite this chapter

White, R.P., Sullivan, J.F., Stenzel, K.H., Rubin, A.L. (1979). Blood Pressure Control in Chronic Dialysis Patients. In: Drukker, W., Parsons, F.M., Maher, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-9327-3_27

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-9327-3_27

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-247-2227-3

  • Online ISBN: 978-94-009-9327-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation